Since PPAR-γ and adiponectin mRNA levels are decreased in the pulmonary artery, and adiponectin circulating levels are also low in mice with obesity, we treated these mice with an agonist of PPAR-γ, PIO. This evidence concerns the gene PPARG and obesity disorder.